Terms: = Lung cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
74 results:
1. Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell lung cancer.
Sakamoto T; Matsubara T; Takahama T; Yokoyama T; Nakamura A; Tokito T; Okamoto T; Akamatsu H; Oki M; Sato Y; Tobino K; Ikeda S; Mori M; Mimura C; Maeno K; Miura S; Harada T; Nishimura K; Hiraoka M; Kenmotsu H; Fujimoto J; Shimokawa M; Yamamoto N; Nakagawa K
JAMA Netw Open; 2023 Dec; 6(12):e2347700. PubMed ID: 38100106
[TBL] [Abstract] [Full Text] [Related]
2. Using Radiomics to Differentiate Brain Metastases From lung cancer Versus Breast cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract] [Full Text] [Related]
3. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract] [Full Text] [Related]
5. Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Mang A; Zou W; Rolny V; Reck M; Cigoianu D; Schulze K; Holdenrieder S; Socinski MA; Shames DS; Wehnl B; Patil NS
Tumour Biol; 2024; 46(s1):S177-S190. PubMed ID: 37545290
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)G.H.Sungetal against lung adenocarcinoma.
Zhang X; Wang M; Liang X; Wang J; Zhang M; Li C; Wei L; Bi H
J Ethnopharmacol; 2023 Dec; 317():116739. PubMed ID: 37315647
[TBL] [Abstract] [Full Text] [Related]
7. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
8. Integrative Analysis of a Large Real-World Cohort of Small Cell lung cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM
Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002
[TBL] [Abstract] [Full Text] [Related]
9. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Cepharanthine on the Stemness of lung Squamous Cell Carcinoma Based on Network Pharmacology and Bioinformatics.
Liu B; Deng JX
Biomed Res Int; 2022; 2022():5956526. PubMed ID: 36483630
[TBL] [Abstract] [Full Text] [Related]
11. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
Paternot S; Raspé E; Meiller C; Tarabichi M; Assié JB; Libert F; Remmelink M; Bisteau X; Pauwels P; Blum Y; Le Stang N; Tabone-Eglinger S; Galateau-Sallé F; Blanquart C; Van Meerbeeck JP; Berghmans T; Jean D; Roger PP
Mol Oncol; 2024 Apr; 18(4):866-894. PubMed ID: 36453028
[TBL] [Abstract] [Full Text] [Related]
12. Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma.
Saddozai UAK; Wang F; Khattak S; Akbar MU; Badar M; Khan NH; Zhang L; Zhu W; Xie L; Li Y; Ji X; Guo X
Cells; 2022 Sep; 11(18):. PubMed ID: 36139498
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients with locally advanced, unresectable, stage Ⅲ nsclc in china.
Jiang X; Chen J; Zheng M; Jia H
PLoS One; 2022; 17(6):e0270118. PubMed ID: 35749385
[TBL] [Abstract] [Full Text] [Related]
14. Serum Extracellular Nano-Vesicles miR-153-3p to Identify Micronodular lung cancer from Sub-Centimeter lung Nodules.
Deng Y; Xue R; Patel N; Xu W; Zhang H
J Biomed Nanotechnol; 2022 Mar; 18(3):705-717. PubMed ID: 35715903
[TBL] [Abstract] [Full Text] [Related]
15. KBTBD7 promotes non-small cell lung carcinoma progression by enhancing ubiquitin-dependent degradation of PTEN.
Zou Z; Zhang B; Li Z; Lei L; Sun G; Jiang X; Guan J; Zhang Y; Xu S; Li Q
Cancer Med; 2022 Dec; 11(23):4544-4554. PubMed ID: 35499228
[TBL] [Abstract] [Full Text] [Related]
16. Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P; Teerapakpinyo C; Korphaisarn K; Leelayuwatanakul N; Pornpatrananrak N; Poungvarin N; Chantranuwat P; Shuangshoti S; Aporntewan C; Chintanapakdee W; Sriuranpong V; Vinayanuwattikun C
Sci Rep; 2022 Feb; 12(1):2167. PubMed ID: 35140316
[TBL] [Abstract] [Full Text] [Related]
17. Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada M; Forbes H; Ashley S; Fenwick J
J Thorac Oncol; 2022 Apr; 17(4):532-543. PubMed ID: 35092841
[TBL] [Abstract] [Full Text] [Related]
18. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell lung cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract] [Full Text] [Related]
19. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
Tang K; Seo J; Tiu BC; Le TK; Pahalyants V; Raval NS; Ugwu-Dike PO; Zubiri L; Naranbhai V; Carrington M; Gusev A; Reynolds KL; LeBoeuf NR; Asgari MM; Kwatra SG; Semenov YR
JAMA Dermatol; 2022 Feb; 158(2):189-193. PubMed ID: 35019948
[TBL] [Abstract] [Full Text] [Related]
20. Multiple bronchiolar adenomas with malignant transformation and ccne1 mutation: a case report and literature review.
Li X; Wu Y; Hui D; Luo X; Wu W; Zhang J; Chen H
J Cardiothorac Surg; 2021 Oct; 16(1):307. PubMed ID: 34663408
[TBL] [Abstract] [Full Text] [Related]
[Next]
